BioSpace News Archive

Feb. 24, 2020 12:58 UTC Shionogi’s FETROJA ® (cefiderocol) Now Available for the Treatment of Complicated Urinary Tract Infections in the U.S. OSAKA, Japan & FLORHAM PARK, N.J.--( BUSINESS WIRE )-- Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced FETROJA ® (cefiderocol) is now available in the U.S. for patients 18 years of age or older who have limited or no alternative treatment options, for the treatment of complicated urinary tract infections (cUTIs), includ

Feb. 24, 2020 13:00 UTC -- Twist Comprehensive Exome Offers Maximum Sequence Efficiency with Best Coverage Uniformity to Increase Confidence in Gene Variant Detection -- -- Previews of Twist Targeted Methylation Solution to Investigate Differentially Methylated Regions for Epigenetic and Oncology Research -- -- Speakers from Ancestry, TwinStrand and University of Cambridge to Share Experience with Twist NGS Products -- SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-

Randy Cooper, MD presents first four-year data on the vascular access innovation at national nephrology conference

Feb. 24, 2020 13:00 UTC Teva Announces FDA Approval of ArmonAir ® Digihaler™ (fluticasone propionate) Inhalation Powder Teva’s Digital Inhaler Portfolio Now Includes Products from Three of the Most Commonly Prescribed Classes of Asthma Treatments TEL AVIV & PARSIPPANY, N.J.--( BUSINESS WIRE )-- Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved Arm

Feb. 24, 2020 13:12 UTC MADISON, Wis.--( BUSINESS WIRE )-- Promega Corporation, a global biotechnology manufacturer, today launched its new Wizard® HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA. The kit, as demonstrated in a poster presented at this week’s 2020 Advances in Genome Biology and Technology (AGBT) meeting, enables researchers to obtain DNA that will provide strong performance in long-read sequencing applications in a 90-minute m

Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, announces that it has completed its Series A round of financing.

Feb. 24, 2020 13:00 UTC Resolution ctDx Lung assay has a demonstrated ability to provide clinically actionable results that can inform care decisions for NSCLC patients KIRKLAND, Wash.--( BUSINESS WIRE )-- Resolution Bioscience, Inc. , today announced an agreement with LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, to make the Resolution ctDx™ Lung assay available to clinicians and patients. The fast, accu

Former Cerner and Allscripts SVP Joins EarlySense to Deepen Existing Relationships and Broaden New Global Opportunities

SUMMIT, N.J. , Feb. 24, 2020 /PRNewswire/ -- Quadrivalent formulation of the first-and-only adjuvanted seasonal influenza vaccine for older adults (65+ years) receives FDA approval 1 Designed with MF59® adjuvant to help strengthen, broaden and lengthen the body’s immune response against the influenza strains contained in the vaccine 1,2,3,4 Seqirus announced to

Feb. 24, 2020 13:30 UTC – MGTA-117 ADC clinical candidate for conditioning showed broad tolerability and wide pre-clinical safety margins – – MGTA-117 demonstrated robust anti-tumor activity in xenograft models from patients with refractory leukemia – – Magenta plans to move MGTA-117 into the clinic with initial clinical data in 2021 – – Landmark data with tool CD117-ADC demonstrate first successful gene therapy transplant without chemotherapy in non-human primates, awar